The largest database of trusted experimental protocols

Msto 211h msto

Sourced in United States

MSTO-211H (MSTO) is a cell line derived from a human malignant mesothelioma. It is an adherent cell line that can be used for in vitro studies.

Automatically generated - may contain errors

2 protocols using msto 211h msto

1

Malignant Mesothelioma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 2

A CD26-negative malignant mesothelioma cell line MSTO-211H (MSTO) (American Type Cell Culture Collection, Manassas, Va.) was transfected with CD26 gene, which was designated as MSTO clone 12 (Aoe K et al., Clin Cancer Res. (2012) 18: 1447-56). A CD26-negative T-cell leukemia cell line Jurkat (American Type Cell Culture Collection, Manassas, Va.) was transfected with CD26 gene, which was designated as Jurkat CD26(+) (Tanaka T et al., Proc Natl Acad Sci USA (1993) 90: 4586-90). A CD26-positive cell line JMN established from malignant mesothelioma was kindly provided by professor Chikao Morimoto, the Institute of Medical Science, the University of Tokyo. All the cell lines were cultured in RPMI medium (catalog No. 11875-093, Life Technologies Corp., Carlsbad, Calif.) containing 10% heat-inactivated fetal bovine serum (FBS, Life Technologies Corp., Carlsbad, Calif.), ABPC (100 μg/ml), and streptomycin (100 μg/ml) at 37° C. under 5% CO2 environment.

+ Open protocol
+ Expand
2

Establishing CD26-Expressing Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSTO-211H (MSTO) (American Type Cell Culture Collection, Manassas, VA, USA), a CD26-negative malignant mesothelioma cell line, was transfected with the CD26 gene and designated MSTO-clone12 [13 (link)]. Jurkat (American Type Cell Culture Collection), CD26 negative T-cell leukemia cell line, was transfected with the CD26 gene and designated Jurkat CD26(+) [39 (link)]. JMN, a CD26-positive cell line established from malignant mesothelioma, was provided by the Clinical Research Center, Institute of Medical Science, University of Tokyo. All the cell lines were grown in the RPMI medium (Cat No. 11875-093, Life Technologies, Carlsbad, CA, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS, Life Technologies), ABPC (100 µg/mL), Streptomycin (100 µg/mL), 37 °C, 5% CO2. dHMVEC (American Type Cell Culture Collection), primary dermal human microvascular endothelial cells were grown in the EGM-2MV Bullet Kit medium (Lonza, Basel, Switzerland) at 37 °C, 5% CO2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!